ENvue Medical, Inc.
FEED
$1.16
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2,620.00% | 115.23% | -34.19% | -74.35% | -43.39% |
| Total Depreciation and Amortization | 0.39% | -29.40% | 1,922.22% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 429.86% | -265.93% | -232.53% | 202.62% | 107.61% |
| Change in Net Operating Assets | 918.18% | -82.02% | -33.99% | -19.65% | 888.57% |
| Cash from Operations | -35.84% | 41.77% | -151.90% | -145.07% | 34.45% |
| Capital Expenditure | 17.86% | -600.00% | 20.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 17.86% | -600.00% | -102.80% | -- | -- |
| Total Debt Issued | -160.61% | 578.26% | -165.71% | -- | -- |
| Total Debt Repaid | 100.00% | 51.85% | -- | -- | -- |
| Issuance of Common Stock | -87.66% | 1,029.46% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 100.00% | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.69% | -28.18% | 552.38% | -- | 100.00% |
| Foreign Exchange rate Adjustments | 450.00% | 50.00% | -300.00% | 80.00% | -150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -193.36% | -15.58% | 2,390.73% | 72.69% | 36.07% |